NAME A randomized phase II trial evaluating the efficacy of a nivolumab monotherapy lead in “window” or commencement of nivolumab concurrently with paclitaxel and carboplatin as neoadjuvant therapy in early stage triple negative breast cancers.
CANCER TYPE Breast cancer
INSTITUTION ANZ Breast Cancer Trails
STATE New South Wales
GRANT TYPE Other
PROJECT TYPE Senior Research Grant